HB
The startup develops an artificial intelligence-powered coronary artery disease risk prediction tool that integrates DNA testing and wearable biosensors for real-time arrhythmia detection. This technology enables cardiologists to provide personalized risk assessments and continuous monitoring, improving management of heart conditions through actionable health insights.
Updated 3 months ago
Funding
$200K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops an artificial intelligence-powered coronary artery disease risk prediction tool that integrates DNA testing and wearable biosensors for real-time arrhythmia detection. This technology enables cardiologists to provide personalized risk assessments and continuous monitoring, improving management of heart conditions through actionable health insights.